Promakhos Therapeutics

Summer 2021Active

A therapeutics platform for curing inflammatory disorders

Save

Summer 2021Active

A therapeutics platform for curing inflammatory disorders

Save

Company details

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Location

Boston, MA, USA

Founded

Unknown

Request the Promakhos Therapeutics report.

Promakhos Therapeutics has no report yet. Sign in with your email to request one.